Brainsway (BWAY) Free Cash Flow (QoQ) (2018 - 2026)
Brainsway (BWAY) Free Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.99% |
| Dec 31, 2025 | -192.45% |
| Sep 30, 2025 | -83.87% |
| Jun 30, 2025 | 123.84% |
| Mar 31, 2025 | 37.04% |
| Dec 31, 2024 | 23.45% |
| Sep 30, 2024 | 63.01% |
| Jun 30, 2024 | -43.75% |
| Mar 31, 2024 | 33.81% |
| Dec 31, 2023 | 55.94% |
| Sep 30, 2023 | -24.96% |
| Jun 30, 2023 | 170.38% |
| Mar 31, 2023 | -57.87% |
| Dec 31, 2022 | -0.90% |
| Sep 30, 2022 | 3.60% |
| Jun 30, 2022 | 22.80% |
| Mar 31, 2022 | -1,190.15% |
| Dec 31, 2021 | 166.83% |
| Sep 30, 2021 | 67.99% |
| Jun 30, 2021 | -152.66% |